VarmX closes seed round
VarmX said June 27 that it closed a seed financing round. New investors include BioGeneration Ventures (BGV) and InnovationQuarter. VarmX, of Leiden, Netherlands, is a biotech company focusing on the development of therapies in the field of hemostasis and thrombosis.
27 June 2017•4 mins read
